[1]

Walsh G, Walsh E. 2022. Biopharmaceutical benchmarks 2022. Nature Biotechnology 40(12):1722−1760

doi: 10.1038/s41587-022-01582-x
[2]

Sergeeva D, Lee GM, Nielsen LK, Grav LM. 2020. Multicopy targeted integration for accelerated development of high-producing Chinese hamster ovary cells. ACS Synthetic Biology 9(9):2546−2561

doi: 10.1021/acssynbio.0c00322
[3]

Feary M, Moffat MA, Casperson GF, Allen MJ, Young RJ. 2021. CHOK1SV GS-KO SSI expression system: a combination of the Fer1L4 locus and glutamine synthetase selection. Biotechnology Progress 37(4):e3137

doi: 10.1002/btpr.3137/v2/review1
[4]

Hagedorn C, Schnödt-Fuchs M, Boehme P, Abdelrazik H, Lipps HJ, et al. 2017. S/MAR element facilitates episomal long-term persistence of adeno-associated virus vector genomes in proliferating cells. Human Gene Therapy 28(12):1169−1179

doi: 10.1089/hum.2017.025
[5]

Sizer RE, White RJ. 2023. Use of ubiquitous chromatin opening elements (UCOE) as tools to maintain transgene expression in biotechnology. Computational and Structural Biotechnology Journal 21:275−283

doi: 10.1016/j.csbj.2022.11.059
[6]

Grav LM, Sergeeva D, Lee JS, Marin de Mas I, Lewis NE, et al. 2018. Minimizing clonal variation during mammalian cell line engineering for improved systems biology data generation. ACS Synthetic Biology 7(9):2148−2159

doi: 10.1021/acssynbio.8b00140
[7]

Hamaker NK, Lee KH. 2018. Site-specific integration ushers in a new era of precise CHO cell line engineering. Current Opinion in Chemical Engineering 22:152−160

doi: 10.1016/j.coche.2018.09.011
[8]

Turan S, Zehe C, Kuehle J, Qiao J, Bode J. 2013. Recombinase-mediated cassette exchange (RMCE) − a rapidly-expanding toolbox for targeted genomic modifications. Gene 515(1):1−27

doi: 10.1016/j.gene.2012.11.016
[9]

Carver J, Ng D, Zhou M, Ko P, Zhan D, et al. 2020. Maximizing antibody production in a targeted integration host by optimization of subunit gene dosage and position. Biotechnology Progress 36(4):e2967

doi: 10.1002/btpr.2967
[10]

Pristovšek N, Nallapareddy S, Grav LM, Hefzi H, Lewis NE, et al. 2019. Systematic evaluation of site-specific recombinant gene expression for programmable mammalian cell engineering. ACS Synthetic Biology 8(4):758−774

doi: 10.1021/acssynbio.8b00453
[11]

Johari YB, Brown AJ, Alves CS, Zhou Y, Wright CM, et al. 2019. CHO genome mining for synthetic promoter design. Journal of Biotechnology 294:1−13

doi: 10.1016/j.jbiotec.2019.01.015
[12]

Brown AJ, Gibson SJ, Hatton D, James DC. 2017. In silico design of context-responsive mammalian promoters with user-defined functionality. Nucleic Acids Research 45(18):10906−10919

doi: 10.1093/nar/gkx768
[13]

Sou SN, Harris CL, Williams R, Kozub D, Zurlo F, et al. 2023. CHO synthetic promoters improve expression and product quality of biotherapeutic proteins. Biotechnology Progress 39(5):e3348

doi: 10.1002/btpr.3348
[14]

Blanco N, Williams AJ, Tang D, Zhan D, Misaghi S, et al. 2020. Tailoring translational strength using Kozak sequence variants improves bispecific antibody assembly and reduces product-related impurities in CHO cells. Biotechnology and Bioengineering 117(7):1946−1960

doi: 10.1002/bit.27347
[15]

Gay R, Kallmeier R, Norman A, Kalwy S. 2008. Mammalian expression vector comprising the mCMV promoter and first intron of hCMV major immediate early gene. European Patent No. EP-1874929-A2. https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20080109&DB=&locale=en_EP&CC=EP&NR=1874929A2&KC=A2&ND=1
[16]

Jin L, Nawab S, Xia M, Ma X, Huo YX. 2019. Context-dependency of synthetic minimal promoters in driving gene expression: a case study. Microbial Biotechnology 12(6):1476−1486

doi: 10.1111/1751-7915.13489
[17]

Smith RP, Taher L, Patwardhan RP, Kim MJ, Inoue F, et al. 2013. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Nature Genetics 45(9):1021−1028

doi: 10.1038/ng.2713
[18]

Kim M, O'Callaghan PM, Droms KA, James DC. 2011. A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnology and Bioengineering 108(10):2434−2446

doi: 10.1002/bit.23189
[19]

Yang Y, Mariati, Chusainow J, Yap MGS. 2010. DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. Journal of Biotechnology 147(3−4):180−185

doi: 10.1016/j.jbiotec.2010.04.004
[20]

Bevilacqua A, Ceriani MC, Capaccioli S, Nicolin A. 2003. Post-transcriptional regulation of gene expression by degradation of messenger RNAs. Journal of Cellular Physiology 195(3):356−372

doi: 10.1002/jcp.10272
[21]

Schaefke B, Sun W, Li YS, Fang L, Chen W. 2018. The evolution of posttranscriptional regulation. WIREs RNA 9(5):e1485

doi: 10.1002/wrna.1485
[22]

Corbett AH. 2018. Post-transcriptional regulation of gene expression and human disease. Current Opinion in Cell Biology 52:96−104

doi: 10.1016/j.ceb.2018.02.011
[23]

Shi J, Wang Q, Li T, Jin X, Ying H, et al. 2023. Antigen-binding molecules that specifically bind EGFR and CD28 and their medicinal uses. PCT Patent No. WO 2023/198042-A1. https://patentscope2.wipo.int/search/zh/detail.jsf?docId=WO2023198042&_gid=202342
[24]

Klein JC, Agarwal V, Inoue F, Keith A, Martin B, et al. 2020. A systematic evaluation of the design and context dependencies of massively parallel reporter assays. Nature Methods 17(11):1083−1091

doi: 10.1038/s41592-020-0965-y
[25]

Arnold CD, Gerlach D, Stelzer C, Boryń ŁM, Rath M, et al. 2013. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339(6123):1074−1077

doi: 10.1126/science.1232542
[26]

Jores T, Tonnies J, Wrightsman T, Buckler ES, Cuperus JT, et al. 2021. Synthetic promoter designs enabled by a comprehensive analysis of plant core promoters. Nature Plants 7(6):842−855

doi: 10.1038/s41477-021-00932-y
[27]

Kotopka BJ, Smolke CD. 2020. Model-driven generation of artificial yeast promoters. Nature Communications 11(1):2113

doi: 10.1038/s41467-020-15977-4
[28]

Thaisuchat H, Baumann M, Pontiller J, Hesse F, Ernst W. 2011. Identification of a novel temperature sensitive promoter in CHO cells. BMC Biotechnology 11:51

doi: 10.1186/1472-6750-11-51
[29]

Fomina-Yadlin D, Mujacic M, Maggiora K, Quesnell G, Saleem R, et al. 2015. Transcriptome analysis of a CHO cell line expressing a recombinant therapeutic protein treated with inducers of protein expression. Journal of Biotechnology 212:106−115

doi: 10.1016/j.jbiotec.2015.08.025
[30]

Sha S, Bhatia H, Yoon S. 2018. An RNA-seq based transcriptomic investigation into the productivity and growth variants with Chinese hamster ovary cells. Journal of Biotechnology 271:37−46

doi: 10.1016/j.jbiotec.2018.02.008
[31]

Curtin JA, Dane AP, Swanson A, Alexander IE, Ginn SL. 2008. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct. Gene Therapy 15(5):384−390

doi: 10.1038/sj.gt.3303105
[32]

Wellen KE, Thompson CB. 2010. Cellular metabolic stress: considering how cells respond to nutrient excess. Mollecular Cell 40(2):323−332

doi: 10.1016/j.molcel.2010.10.004
[33]

Brown AJ, Sweeney B, Mainwaring DO, James DC. 2015. NF-κB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells. Biotechnology Journal 10(7):1019−1028

doi: 10.1002/biot.201400744
[34]

Patel YD, Brown AJ, Zhu J, Rosignoli G, Gibson SJ, et al. 2021. Control of multigene expression stoichiometry in mammalian cells using synthetic promoters. ACS Synthetic Biology 10(5):1155−1165

doi: 10.1021/acssynbio.0c00643
[35]

Dong E, Lam C, Tang D, Louie S, Yim M, et al. 2021. Concurrent transfection of randomized transgene configurations into targeted integration CHO host is an advantageous and cost-effective method for expression of complex molecules. Biotechnology Journal 16(4):e2000230

doi: 10.1002/biot.202000230
[36]

Lee JS, Kallehauge TB, Pedersen LE, Kildegaard HF. 2015. Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway. Scientific Reports 5:8572

doi: 10.1038/srep08572